Archiv SCREENING

Drug Discovery

Changing Gears? Not So Fast, Please

R. Macarron, President of the Society for Biomolecular Sciences

Seite 01

Label-free Technologies in Drug Discovery

SBS Symposium in Dresden

Seite 08

Polymorphism & Patenting

Seite 08

Reincarnation In Biotech

Is There Life After Death?

M. Brännback et al., Åbo Akademi University, Finland

Seite 010

Antibody Microarray-based Screening

Label-dependent vs. Label-free Detection

C. Wingren et al., Lund University, Sweden

Seite 012

Kinase Assay Development

A Strategy for Comprehensive Kinase Profiling for Drug Discovery

M. Gouda, Carna Biosciences, Japan

Seite 015

Therapeutic Antibodies

Structure Assessment by Mass Spectrometry from Screening to Clinical Batches

A. Beck et al., Centre d’Immunologie Pierre Fabre (CIPF), France

Seite 018

The Grand Challenge for European Biology

Part II: Networks for Life

H. V. Westerhoff, Manchester Interdisciplinary Biocentre, United Kingdom

Seite 022

A View on Screening Platforms

Antibody Screening Gets Extreme Makeover

K.J. Morrow Jr., Newport Biotech Consultants, USA

Seite 024

Biotechnology-derived Therapeutics

Immunogenicity – the Regulatory Point of View

E.-M. Jahn et al., Paul-Ehrlich-Institut, Langen Germany

Seite 028

Physical Plasma

Its Possible Use in Medicine

U. Lindequist et al., University of Greifswald, Germany

Seite 032

A New Generation of Discovery

Applied Biosystems' SOLiD System

M. Rhodes, Applied Biosystems, USA

Seite 034

Transport Proteins the Final Frontier?

From Clamping to Surfing in No Time

IonGate Biosciences, Germany

Seite 036

Rapid, Fail-early Screening

Streamlining Drug Discovery

Genetix, United Kingdom

Seite 038

New Reproter Gene Technology

Monitoring Transfection Using Luciferase Reporter Assays

M. Stosik et al., amaxa, Germany

Seite 040

Mechanisms Of Metastasis

Cellix’s VenaFlux Platform Pursues Metastatic Movement

K. Fitzgerald et al., Cellix, Ireland

Seite 042

Non Binding Surfaces

A New Technology for Assay Development and HTS

R. Heller, Greiner Bio-One, Germany

Seite 044